Evidence map›Paper›PMID 35611270›Full record

ArticleNeuro-oncology advances

Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent

John F de Groot, Albert H Kim, Sujit Prabhu, Ganesh Rao, Adrian W Laxton, Peter E Fecci, Barbara J O'Brien, Andrew Sloan, Veronica Chiang, Stephen B Tatter and 15 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02392078 (Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System), which is not on this map. Cited by 54 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 4 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02392078 completednot on this map

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry

TypeobservationalSponsorMonteris MedicalRan2015 to 2023Enrolled1,153ConditionsMetastatic Brain Tumor, Primary Brain Tumor, Epileptic/Seizure Foci, Movement DisordersArmsNeuroBlate System
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. MRI-guided laser ablation for pediatric intracranial pathology: single center experience.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Adapting Laser Interstitial Thermal Therapy for the Treatment of Naturally Occurring Intracranial Tumors in Dogs.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 19 institutions in 1 country.

John F de GrootDepartment of Neuro-Oncology, UCSF Weill Institute for Neurosciences, San Francisco, California,USA.
Albert H KimDepartment of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Sujit PrabhuDepartment of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ganesh RaoDepartment of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
Adrian W LaxtonDepartment of Neurosurgery, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA.
Peter E FecciDepartment of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Barbara J O'BrienDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Andrew SloanDepartment of Neurosurgery, University Hospitals-Cleveland Medical Center & Seidman Cancer Center, Cleveland, Ohio, USA.
Veronica ChiangDepartment of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA.
Stephen B TatterDepartment of Neurosurgery, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA.
Alireza M MohammadiDepartment of Neurosurgery, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland, Ohio, USA.
Dimitris G PlacantonakisDepartment of Neurosurgery, NYU Grossman School of Medicine, New York, New York, USA.
Roy E StrowdDepartment of Neuro-Oncology, Wake Forest Baptist Health, Winston- Salem, North Carolina, USA.
Clark ChenDepartment of Neurosurgery, University of Minnesota Medical Center, Minneapolis, Minnesota, USA.
Constantinos HadjipanayisDepartment of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mustafa KhasrawDepartment of Neuro-Oncology, Duke University Medical Center, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0003-3249-9849
David SunDepartment of Neurosurgery, Norton Neuroscience Institute, Louisville, Kentucky, USA.
David PiccioniDepartment of Neuro-Oncology, University of California San Diego Health, La Jolla, California, USA.
Kaylyn D SinicropeDepartment of Neuro-Oncology, Norton Neuroscience Institute, Louisville, Kentucky, USA.
Jian L CampianDepartment of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Sylvia C KurzDepartment of Neuro-Oncology, NYU Langone Perlmutter Cancer Center, New York, New York, USA.
Brian WilliamsDepartment of Neurosurgery, University of Louisville Health, Louisville, Kentucky, USA.
Kris SmithDepartment of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA.
Zulma Tovar-SpinozaDepartment of Neurosurgery, SUNY Upstate Medical University, Syracuse, New York, USA.
Eric C LeuthardtDepartment of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Atrium Health Wake Forest Baptist · USDuke Medical Center · USNorton Healthcare · USThe University of Texas MD Anderson Cancer Center · USWashington University in St. Louis · USBarrow Neurological Institute · USBaylor College of Medicine · USCenter for Neuro-Oncology · USCenter for Neurosciences · USCleveland Clinic Lerner College of Medicine · USIcahn School of Medicine at Mount Sinai · USMayo Clinic · USNew York University · USSUNY Upstate Medical University · USUniversity Hospitals Seidman Cancer Center · USUniversity of California San Diego · USUniversity of Louisville · USUniversity of Minnesota Medical Center · USYale University · US

Funding

The role of GPR133 in glioblastomaR01NS102665 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PLACANTONAKIS, DIMITRIS G. · 2018 to 2022
$2.3M
NINDS NIH HHS R01 NS102665
6 · The paper itself

Abstract

Background: Treatment options for unresectable new and recurrent glioblastoma remain limited. Laser ablation has demonstrated safety as a surgical approach to treating primary brain tumors. The LAANTERN prospective multicenter registry (NCT02392078) data were analyzed to determine clinical outcomes for patients with new and recurrent Methods: Demographics, intraprocedural data, adverse events, KPS, health economics, and survival data were prospectively collected and then analyzed on Results: A total of 29 new and 60 recurrent Conclusions: Laser ablation is a viable option for patients with new and recurrent glioblastoma. Median OS for

Indexed as

high-grade gliomaIDH wild-type WHO grade 4 glioblastomalaser interstitial thermal therapy (LITT)primary brain tumorstereotactic laser ablation (SLA)

Identifiers

PMID35611270
PMCPMC9122789
OpenAlexW4225573601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.